Bioceres, an Argentine developer of crop productivity traits for genetically modified seeds, filed on Monday with the SEC to raise up to $100 million in an initial public offering.
The Rosario, Argentina-based company was founded in 2002 and booked $123 million in sales for the 12 months ended September 30, 2017. It plans to list on the NYSE under the symbol BIOX. Bioceres filed confidentially on May 20, 2015. Jefferies, Piper Jaffray and Banco Santander are the joint bookrunners on the deal. No pricing terms were disclosed.
